| Date | Time | Source | Headline | Symbol | Company |
| 18/11/2017 | 08:07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 14/11/2017 | 22:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 10/11/2017 | 09:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 09:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 03:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 02:24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 01:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 01:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 01:18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 01:17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 01:15 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 00:57 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 08/11/2017 | 00:43 | GlobeNewswire Inc. | Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 08:08 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 28/10/2017 | 08:04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 26/10/2017 | 23:55 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 26/10/2017 | 23:48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 26/10/2017 | 23:30 | GlobeNewswire Inc. | Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 24/10/2017 | 02:15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 24/10/2017 | 02:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 18/10/2017 | 01:38 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
